日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Guidelines for the welfare and use of animals in cancer research

癌症研究中动物福利和使用指南

Workman, P; Aboagye, E O; Balkwill, F; Balmain, A; Bruder, G; Chaplin, D J; Double, J A; Everitt, J; Farningham, D A H; Glennie, M J; Kelland, L R; Robinson, V; Stratford, I J; Tozer, G M; Watson, S; Wedge, S R; Eccles, S A

VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.

VEGF-A、VEGF-C 和 VEGF-D 在结直肠癌进展中的作用

George M L, Tutton M G, Janssen F, Arnaout A, Abulafi A M, Eccles S A, Swift R I

Monoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?

靶向癌症的单克隆抗体:是“灵丹妙药”还是仅仅是触发因素?

Eccles, S A

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour

比较单个肿瘤分泌白细胞介素2或白细胞介素4的潜在治疗效果

Patel, P M; Flemming, C L; Russell, S J; McKay, I A; MacLennan, K A; Box, G M; Eccles, S A; Collins, M K

Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. II. Effect of host age and immune status

放射性标记的大鼠单克隆抗体识别同源肉瘤抗原的药代动力学研究。II. 宿主年龄和免疫状态的影响

Eccles, S A; Purvies, H P; Styles, J M; Hobbs, S M; Dean, C J

Pharmacokinetic studies of radiolabelled rat monoclonal antibodies recognising syngeneic sarcoma antigens. I. Comparison of IgG subclasses

放射性标记的大鼠单克隆抗体识别同源肉瘤抗原的药代动力学研究。I. IgG亚类的比较

Eccles, S A; Purvies, H P; Styles, J M; Hobbs, S M; Dean, C J

An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chain

一种无效的单克隆抗体-蓖麻毒素A链缀合物,通过随后全身性给予蓖麻毒素B链,可在体内转化为一种肿瘤杀伤剂。

Eccles, S A; McIntosh, D P; Purvies, H P; Cumber, A J; Parnell, G D; Forrester, J A; Styles, J M; Dean, C J

Failure of suckling to transfer immunity to a syngeneic rat sarcoma

哺乳未能将免疫力转移给同源大鼠肉瘤

Eccles, S A; Alexander, P